Development and Validation of a Novel Prognostic Model for Predicting Overall Survival in Treatment-naïve Castration-sensitive Metastatic Prostate CancerShusuke Akamatsu, Osamu Ogawa, Senji Hoshi et al.|European Urology Oncology|2018Cited by 55
Differential prognostic factors in low‐ and high‐burden de novo metastatic hormone‐sensitive prostate cancer patientsMasaki Shiota, Naoki Terada, Toshihiro Saito et al.|Cancer Science|2020Cited by 48
Prostate cancer and liquid biopsies: Clinical applications and challengesFumihiko Urabe, Takashi Kobayashi, Takayuki Sumiyoshi et al.|International Journal of Urology|2024Cited by 24
Potential effectiveness of local radiotherapy for extending survival and reducing symptomatic local events in patients with de novo metastatic prostate cancerNaoki Terada, Takashi Mizowaki, Toshihiro Saito et al.|BJUI Compass|2020Cited by 19
Novel metastatic burden‐stratified risk model in de novo metastatic hormone‐sensitive prostate cancerMasaki Shiota, Naoki Terada, Hiroshi Kitamura et al.|Cancer Science|2021Cited by 15